These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8573394

  • 21. Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein.
    Echetebu CO, Rice AP.
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):550-7. PubMed ID: 8496787
    [Abstract] [Full Text] [Related]

  • 22. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
    Derse D, Dorn P, DaSilva L, Martarano L.
    Dev Biol Stand; 1990 Jun; 72():39-48. PubMed ID: 2178129
    [Abstract] [Full Text] [Related]

  • 23. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ, Zhang C.
    Virology; 1995 Aug 01; 211(1):157-69. PubMed ID: 7645208
    [Abstract] [Full Text] [Related]

  • 24. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ, Karn J.
    EMBO J; 1999 Mar 01; 18(5):1378-86. PubMed ID: 10064603
    [Abstract] [Full Text] [Related]

  • 25. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM, Jeang KT.
    Arch Biochem Biophys; 1999 May 15; 365(2):175-85. PubMed ID: 10328810
    [Abstract] [Full Text] [Related]

  • 26. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J, Lenz C, Kammler S, Scheid A, Schaal H.
    Virology; 2001 Aug 01; 286(2):276-89. PubMed ID: 11485396
    [Abstract] [Full Text] [Related]

  • 27. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP, Caputo A, Zucchini S, Bozzini R, Marconi PC, Manservigi R, Barbanti-Brodano G, Balboni PG.
    Year Immunol; 1993 Aug 01; 7():199-204. PubMed ID: 8396820
    [No Abstract] [Full Text] [Related]

  • 28. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA, Gatignol A, Hiscott J.
    Virology; 2002 Apr 25; 296(1):77-83. PubMed ID: 12036319
    [Abstract] [Full Text] [Related]

  • 29. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A, Zoppé M, Giacca M.
    IUBMB Life; 2001 Mar 25; 51(3):175-81. PubMed ID: 11547919
    [Abstract] [Full Text] [Related]

  • 30. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I, Rana TM.
    Biochemistry; 1997 Oct 14; 36(41):12592-9. PubMed ID: 9376365
    [Abstract] [Full Text] [Related]

  • 31. Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?
    Tiley LS, Brown PH, Cullen BR.
    Virology; 1990 Oct 14; 178(2):560-7. PubMed ID: 2219707
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences.
    Guo X, Kameoka M, Wei X, Roques B, Gotte M, Liang C, Wainberg MA.
    Virology; 2003 Mar 01; 307(1):154-63. PubMed ID: 12667823
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.
    Jeyapaul J, Reddy MR, Khan SA.
    Proc Natl Acad Sci U S A; 1990 Sep 01; 87(18):7030-4. PubMed ID: 2205850
    [Abstract] [Full Text] [Related]

  • 38. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
    Elangovan B, Subramanian T, Chinnadurai G.
    J Virol; 1992 Apr 01; 66(4):2031-6. PubMed ID: 1548750
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1.
    Neuveut C, Scoggins RM, Camerini D, Markham RB, Jeang KT.
    J Biomed Sci; 2003 Apr 01; 10(6 Pt 1):651-60. PubMed ID: 14576468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.